Natchaya Polpichai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Natchaya Polpichai has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Angkawipa Trongtorsak
Department of Cardiovascular Medicine Virginia Commonwealth University Richmond Virginia USA
1 shared publication - Hussein Krayem
Internal Medicine, Virginia Commonwealth University, Richmond, VA 23230, USA
1 shared publication - Kimberly Renae Ding
Internal Medicine, Harbor-UCLA Medical Center, Torrance, USA
1 shared publication - Mathurin Suwanwalaikorn
Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
1 shared publication - Narut Prasitlumkum
Department of Cardiovascular Medicine Pali Momi Medical Center, Hawaii, Pacific Health Aiea Hawaii USA
1 shared publication - Omar Khalil
Internal Medicine, Virginia Commonwealth University, Richmond, VA 23230, USA
1 shared publication
Latest Publications
- Open Access
- 4 July 2024
- Published by MDPI AG in Journal of Otorhinolaryngology, Hearing and Balance Medicine
- Vol. 5 (2) , 9
Effect of Continuous Positive Airway Pressure after Pulmonary Vein Isolation in Obstructive Sleep Apnea Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis
Background: Obstructive sleep apnea (OSA) was associated with atrial fibrillation (AF) as well as the recurrence of AF after rhythm control strategy. However, the data on continuous positive airway pressure (CPAP) and recurrent AF after catheter ablation with pulmonary vein isolation (PVI) remain unclear. We conducted this systematic review and meta-analysis to evaluate the effect of CPAP treatment in OSA patients after atrial fibrillation ablation. Methods: We searched MEDLINE and Embase databases from inception to September 2023 to identify studies that assess the effect of CPAP in OSA patients on the recurrence of AF after PVI. Data from each study were combined using the random effects model. Results: Eight studies (one randomized controlled trial and seven cohort studies) with 1487 OSA patients (660 in the CPAP group and 827 in the control group) were included. The use of CPAP in OSA patients was associated with significantly lower AF recurrence after PVI (odds ratio (OR) = 0.36, 95% conference interval (CI) 0.25–0.53, p < 0.001). The results of sensitivity analysis remain the same as the main analysis. Conclusions: Our meta-analysis demonstrated that CPAP treatment was associated with lower rates of AF recurrence after PVI.
- 4 July 2024
- Published by MDPI AG in Journal of Otorhinolaryngology, Hearing and Balance Medicine
- Vol. 5 (2) , 9
Open AccessEffect of Continuous Positive Airway Pressure after Pulmonary Vein Isolation in Obstructive Sleep Apnea Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis
Background: Obstructive sleep apnea (OSA) was associated with atrial fibrillation (AF) as well as the recurrence of AF after rhythm control strategy. However, the data on continuous positive airway pressure (CPAP) and recurrent AF after catheter ablation with pulmonary vein isolation (PVI) remain unclear. We conducted this systematic review and meta-analysis to evaluate the effect of CPAP treatment in OSA patients after atrial fibrillation ablation. Methods: We searched MEDLINE and Embase databases from inception to September 2023 to identify studies that assess the effect of CPAP in OSA patients on the recurrence of AF after PVI. Data from each study were combined using the random effects model. Results: Eight studies (one randomized controlled trial and seven cohort studies) with 1487 OSA patients (660 in the CPAP group and 827 in the control group) were included. The use of CPAP in OSA patients was associated with significantly lower AF recurrence after PVI (odds ratio (OR) = 0.36, 95% conference interval (CI) 0.25–0.53, p < 0.001). The results of sensitivity analysis remain the same as the main analysis. Conclusions: Our meta-analysis demonstrated that CPAP treatment was associated with lower rates of AF recurrence after PVI.